SearchDictionaryMobileLogin

Mao-Yuan Chen Selected Research

Highly Active Antiretroviral Therapy (HAART)

05/2008Cytomegalovirus retinitis and immune recovery uveitis in AIDS patients treated with highly active antiretroviral therapy in Taiwanese.
11/2007Evolution of hepatitis B serological markers in HIV-infected patients receiving highly active antiretroviral therapy.
09/2007Risk of recurrent nontyphoid Salmonella bacteremia in HIV-infected patients in the era of highly active antiretroviral therapy and an increasing trend of fluoroquinolone resistance.
08/2007Cost-effectiveness of highly active antiretroviral therapy for HIV infection in Taiwan.
04/2007Impact of hepatitis D virus infection on the long-term outcomes of patients with hepatitis B virus and HIV coinfection in the era of highly active antiretroviral therapy: a matched cohort study.
10/2006Changes in the clinical spectrum of opportunistic illnesses in persons with HIV infection in Taiwan in the era of highly active antiretroviral therapy.
08/2006Improved survival of persons with human immunodeficiency virus type 1 infection in the era of highly active antiretroviral therapy in Taiwan.
10/2005Herpes zoster in HIV-1-infected patients in the era of highly active antiretroviral therapy: a prospective observational study.
07/2004Successful discontinuation of secondary prophylaxis for histoplasmosis after highly active antiretroviral therapy.
12/2003Improved outcomes of HIV-1-infected adults with tuberculosis in the era of highly active antiretroviral therapy.
12/2003Dynamics of plasma hepatitis B virus levels after highly active antiretroviral therapy in patients with HIV infection.
03/2002Discontinuation of secondary prophylaxis for penicilliosis marneffei in AIDS patients responding to highly active antiretroviral therapy.

Articles by Research Topic

Disease

3HIV Infections (HIV Infection)
08/2007 - 12/2003
3Infection
04/2007 - 03/2003
2Acquired Immunodeficiency Syndrome (AIDS)
05/2008 - 03/2002
1Cytomegalovirus Retinitis
05/2008
1Uveitis
05/2008
1Hepatitis B
11/2007
1Bacteremia
09/2007
1Herpes Zoster
10/2005
1Histoplasmosis
07/2004
1Tuberculosis
12/2003

Drug/Important Bio-Agent (IBA)

1Reverse Transcriptase InhibitorsIBA
03/2003
1efavirenz (Sustiva)FDA Link
03/2003

Therapy/Procedure

12Highly Active Antiretroviral Therapy (HAART)
05/2008 - 03/2002